Canada Pension Plan Investment Board’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$3.09M	–	1600
2020 Q4	$3.09M	Buy	100,000 +45,000	+82%	+$1.14M	﹤0.01%	718
2020 Q3	$1.12M	Buy	+55,000	New	+$966K	﹤0.01%	723
2019 Q4	–	Sell	-60,000	Closed	-$902K	–	1493
2019 Q3	$902K	Buy	60,000 +50,000	+500%	+$779K	﹤0.01%	972
2019 Q2	$143K	Sell	10,000 -20,000	-67%	-$319K	﹤0.01%	1138
2019 Q1	$523K	Buy	+30,000	New	+$532K	﹤0.01%	1162

Other funds holding TCRR

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Canada Pension Plan Investment Board's TCRR Position: Q1 2021 in Review

Canada Pension Plan Investment Board sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q1 2021, closing a stake of 100,000 shares — an estimated $3.09M sold.

Canada Pension Plan Investment Board first reported a position in TCRR in Q1 2019 and held it in 5 quarters. The position peaked at $3.09M in Q4 2020. 129 funds tracked by Wall St. Rank hold TCRR as of Q1 2021.

Canada Pension Plan Investment Board reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Canada Pension Plan Investment Board sold 100,000 TCR2 Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $3.09M.
Canada Pension Plan Investment Board first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2019 and held it in 5 quarters.
Canada Pension Plan Investment Board's TCR2 Therapeutics Inc. Common Stock position peaked at $3.09M in Q4 2020.
129 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q1 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2021, filed 17 May 2021.